Benzoditezite (BZO) antibody and antigen (hapten, BSA/OVA conjugated)

Diagnostic anti-Benzoditezite (BZO) antibodies (anti-Benzoditezite, anti-BZO) and diagnostic hapten-carrier conjugates BSA-Benzoditezite (BZO), OVA-Benzoditezite (BZO), KLH-Benzoditezite (BZO) antigens for Multiple disease BZO detection in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.

Target products collectionGo to Multiple disease diagnostics products collection>>


Product information

Catalog No.DescriptionUS $ Price (per mg)
GMP-SMT-226-Ag01BSA-Benzoditezite (BZO)$756.00
GMP-SMT-226-Ag02OVA-Benzoditezite (BZO)$756.00
GMP-SMT-226-Ab01Anti-human Benzoditezite (BZO) mouse monoclonal antibody (mAb)$1953.00
GMP-SMT-226-Ab02Anti-human Benzoditezite (BZO) human monoclonal antibody (mAb)$1953.00

Size: 1mg | 10mg | 100mg



Product Description

BSA-Benzoditezite (BZO)

Cat No.GMP-SMT-226-Ag01
Product NameBSA-Benzoditezite (BZO)
TargetBenzoditezite (BZO)
Expression platformSynthetic
Bioactivity validationBenzoditezite (BZO) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in BZO level test of Multiple disease and related syndrome evaluation
Products descriptionCompetitive immunoassay-validated hapten-carrier conjugates BSA-Benzoditezite (BZO) / OVA-Benzoditezite (BZO) is Synthetic.
PurityHigh (TBD)
ApplicationCompetitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

OVA-Benzoditezite (BZO)

Cat No.GMP-SMT-226-Ag02
Product NameOVA-Benzoditezite (BZO)
TargetBenzoditezite (BZO)
Expression platformSynthetic
Bioactivity validationBenzoditezite (BZO) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in BZO level test of Multiple disease and related syndrome evaluation
Products descriptionCompetitive immunoassay-validated hapten-carrier conjugates BSA-Benzoditezite (BZO) / OVA-Benzoditezite (BZO) is Synthetic.
PurityHigh (TBD)
ApplicationCompetitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Anti-human Benzoditezite (BZO) mouse monoclonal antibody (mAb)

Cat No.GMP-SMT-226-Ab01
Product NameAnti-human Benzoditezite (BZO) mouse monoclonal antibody (mAb)
TargetBenzoditezite (BZO)
Expression platformhybridoma
IsotypesMouse IgG
Bioactivity validationBenzoditezite (BZO) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Benzoditezite (BZO) antibodies in BZO level test of Multiple disease and related syndrome evaluation.
TagmFc
Products descriptionAnti-human Benzoditezite (BZO) mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by hybridoma technology.
PurityHigh (TBD)
ApplicationCompetitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Anti-human Benzoditezite (BZO) human monoclonal antibody (mAb)

Cat No.GMP-SMT-226-Ab02
Product NameAnti-human Benzoditezite (BZO) human monoclonal antibody (mAb)
TargetBenzoditezite (BZO)
Expression platformhybridoma
IsotypesHuman IgG1
Bioactivity validationBenzoditezite (BZO) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Benzoditezite (BZO) antibodies in BZO level test of Multiple disease and related syndrome evaluation.
TaghFc
Products descriptionAnti-human Benzoditezite (BZO) mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO.
PurityPurity: ≥95% (SDS-PAGE)
ApplicationCompetitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
FormulationSupplied as a 0.2 μM filtered solution of PBS, PH7.4.
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Target/Biomarker information


    Benzodiazepines, a class of psychoactive drugs, are central to managing a broad spectrum of CNS disorders due to their potent anxiolytic, sedative, muscle relaxant, and anticonvulsant effects. These drugs operate by potentiating the action of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA_A receptor, leading to enhanced inhibitory neurotransmission within the brain. While benzodiazepines are effective therapeutic agents, their potential for dependence, tolerance, and withdrawal necessitates careful monitoring. The pivotal role of in vitro diagnostics (IVD) in the detection and quantification of benzodiazepines in biological specimens is underscored by the necessity to balance therapeutic efficacy against the risk of adverse outcomes.

    ### 1. Benzodiazepines in Clinical and Forensic Settings

    In clinical settings, the measurement of benzodiazepine concentrations via IVD assays is crucial for therapeutic drug monitoring (TDM). This process ensures drug levels remain within the therapeutic index, optimizing treatment outcomes for disorders such as anxiety, insomnia, and epilepsy while minimizing side effects. Additionally, in cases of suspected overdose, rapid and accurate benzodiazepine quantification can guide the administration of appropriate interventions, potentially saving lives.

    Moreover, the significance of benzodiazepine measurement extends into forensic toxicology, where it aids in investigating cases of drug misuse, accidental or intentional overdose, and in scenarios involving drug-facilitated crimes. The ability to precisely detect and quantify benzodiazepines supports legal and compliance efforts, particularly in employment and sports settings, where drug-free policies are enforced.

    ### 2. Advanced Diagnostic Technologies for Benzodiazepine Detection

    The development and application of highly specific anti-benzodiazepine antibodies and competitive antigens have revolutionized the field of IVD, enabling the creation of sensitive and specific assays. Techniques such as enzyme-linked immunosorbent assays (ELISA), chemiluminescent immunoassays (CLIA), and liquid chromatography-tandem mass spectrometry (LC-MS/MS) are employed to measure benzodiazepine levels with precision. These methodologies cater to diverse requirements, from rapid point-of-care testing (POCT) to comprehensive laboratory-based analyses, facilitating timely and informed clinical decision-making.

    ### 3. Implications of Benzodiazepine Measurement

    The quantification of benzodiazepines has profound implications across various domains:

    - **Therapeutic Drug Monitoring (TDM):** TDM is vital for personalizing benzodiazepine therapy, ensuring that patients receive dosages that maximize efficacy and minimize the risk of adverse effects or development of dependency. This approach is particularly relevant for long-term treatments and in populations with increased susceptibility to side effects, such as the elderly.

    - **Emergency Medicine:** In acute care settings, identifying benzodiazepine intoxication enables clinicians to administer specific countermeasures, such as flumazenil, a benzodiazepine antagonist, thereby mitigating the risks associated with overdose.

    - **Drug Abuse and Compliance:** Regular monitoring of benzodiazepine levels helps identify patterns of misuse or diversion, facilitating interventions aimed at preventing abuse. Additionally, it ensures that patients adhere to prescribed treatment regimens, crucial for the successful management of underlying conditions.

    - **Forensic and Legal Applications:** Accurate benzodiazepine detection is essential in forensic investigations, contributing to the resolution of legal cases involving drug-facilitated assaults, DUI charges, and workplace drug testing disputes.

    In summary, the measurement of benzodiazepines through advanced IVD technologies plays a critical role in optimizing patient care, safeguarding public health, and supporting forensic and legal processes. The ongoing development of innovative diagnostic reagents and methodologies promises to enhance the precision, efficiency, and utility of benzodiazepine detection in various settings, underscoring the intersection of pharmacology, medicine, and technology in contemporary healthcare and legal systems.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.